Brandon BioCatalyst
The largest life science investment fund in Australia and New Zealand
ANDHealth
Programs support commercialisation of digital health technologies, including CUREator+, an incubator for biomedical and dementia-focused innovations, ANDHealth+ for scaling digital health companies, and ACTIVATE for high-growth ventures in Victoria.
MedTech Innovator Asia Pacific Accelerator
Get high-profile visibility with healthcare investors, stakeholders, and decision-makers, one-on-one mentorship with a network of experienced mentors and peers, plus, you could win up to US$300K.
NHMRC Partnership Projects 2026
Supports collaborations that translate research evidence into Australian health policy and practice to improve health services and systems.
2026 Independent Research Institutes Infrastructure Support Scheme
Allocates funds for infrastructure support to independent medical research institutes managing NHMRC research funds.
2026 Equipment Grants
This funding supports eligible institutions to purchase, maintain and upgrade equipment used in health and medical research.
NHMRC Clinical Trials and Cohort Studies Grants
Supports high-quality clinical trials and cohort studies that fill knowledge gaps and deliver implementable findings to improve health outcomes. Open to projects of any size, with grants up to 5 years
Cancer Council WA Funding
Research funding focussed on projects that have the potential to translate into practice, and result in real improvements for people impacted by cancer.
CICA Lab Incubator Program
Accelerate your business or launch your career in healthcare innovation in a 12-week part-time program.
Bupa Ventures
The corporate investment arm of Bupa, Bupa Ventures invests at the Seed – Series A stage with the ability to follow-on in future rounds. It supports and invests in start-ups that are focused on developing innovative models of healthcare that enable better health outcomes.